Brain scan study tests if Quit-Smoking pill cools cravings
NCT ID NCT06617312
Summary
This study aims to understand how a smoking cessation medication called cytisinicline affects the brain's response to smoking triggers. Researchers will enroll 64 adults who smoke daily but are not currently trying to quit. Participants will take either the medication or a placebo for 2-3 weeks, then undergo a brain scan while viewing smoking-related videos to measure changes in brain activity and craving.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Los Angeles
RECRUITINGLos Angeles, California, 90049, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.